CG
CANO

Cutler Group’s Cano Health, Inc. CANO Stock Holding History

Cutler Group’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-216
Closed -$3K – 4488
2023
Q2 		$3K Buy
+216
New +$27.7K ﹤0.01% 2943
2023
Q1 		– Sell
-1,287
Closed -$10K – 4987
2022
Q4 		$10K Sell
1,287
-187
-13% -$63.3K ﹤0.01% 2737
2022
Q3 		$115K Buy
1,474
+1,151
+356% +$721K 0.01% 1294
2022
Q2 		$1K Sell
323
-1,345
-81% -$701K ﹤0.01% 4819
2022
Q1 		$36K Buy
1,668
+525
+46% +$331K ﹤0.01% 2544
2021
Q4 		$27K Sell
1,143
-296
-21% -$311K ﹤0.01% 2900
2021
Q3 		$161K Buy
1,439
+911
+173% +$1.1M 0.01% 1538
2021
Q2 		$44K Buy
528
+355
+205% +$479K ﹤0.01% 2602
2021
Q1 		$1K Buy
+173
New +$245K ﹤0.01% 5454

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Cutler Group's CANO Position: Q1 2024 in Review

Cutler Group sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 8 shares.

Cutler Group first reported a position in CANO in Q1 2021 and held it in 12 quarters. The position peaked at $724K in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Cutler Group reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 8 Cano Health, Inc. shares in Q1 2024.
  • Cutler Group first reported a position in Cano Health, Inc. in Q1 2021 and held it in 12 quarters.
  • Cutler Group's Cano Health, Inc. position peaked at $724K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.